Gelderblom, H., & Zwaveling, J. (2021). No need for H(2)-antagonists in premedication regimens for paclitaxel infusions: Less is more. Br J Cancer.
Citação norma ChicagoGelderblom, Hans, and Juliette Zwaveling. "No Need for H(2)-antagonists in Premedication Regimens for Paclitaxel Infusions: Less Is More." Br J Cancer 2021.
Citação norma MLAGelderblom, Hans, and Juliette Zwaveling. "No Need for H(2)-antagonists in Premedication Regimens for Paclitaxel Infusions: Less Is More." Br J Cancer 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.